Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - INTEREST INCOME & EXPENSE
Interest Income & Expense ABUS - Arbutus Biopharma Corporation
459 K
LAST VALUE
-59.92%
2 YEAR CAGR
18.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR